SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-10-109177
Filing Date
2010-05-05
Accepted
2010-05-05 17:31:02
Documents
5
Period of Report
2010-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 493899
2 SECTION 302 CERTIFICATION BY PRINCIPAL EXECUTIVE OFFICER dex311.htm EX-31.1 6626
3 SECTION 302 CERTIFICATION BY PRINCIPAL FINANCIAL OFFICER dex312.htm EX-31.2 6689
4 SECTION 906 CERTIFICATION BY PRINCIPAL EXECUTIVE OFFICER dex321.htm EX-32.1 4490
5 SECTION 906 CERTIFICATION BY PRINCIPAL FINANCIAL OFFICER dex322.htm EX-32.2 4354
  Complete submission text file 0001193125-10-109177.txt   517471
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 10803128
SIC: 2834 Pharmaceutical Preparations